Discover Great Companies Discover Great Clients
Popularity  5万   |   Followers  40   |   Likes  18   |   Feedback  39 Claim this company

Technology creates a healthy life

Shanghai Pudong New Area No.4 Dan Bai Zhi Yao Products No.4 Gan An Acids No.4 Dan Bai Yao Products No.4 Yao Wu Shai Xuan No.6 Suo Jia Ji Xian Wei Su No.6 Suo Jia Ji Xian Wei Su Sodium No.6 Amino Acid No.6 Xin Yao Shai Xuan No.7 Biopharmaceuticals R&D No.8 CMC No.8 Ethanol No.9 Dan Ke Long Kang Ti 国药准字 高新技术企业 省级高新技术企业 市级专精特新中小企业 省级创新型中小企业 发明专利 NMPA认证
More

Company Overview

  • Nature: Private Enterprise Size: 500-999 employees Founded: 27年
  • Industry: Pharmaceuticals/Bioengineering
  • Full name: Shanghai Benemae Pharmaceutical Corporation Limited。

Development Stage

  • Ranking: Ranked #4 in Shanghai Dan Bai Zhi Yao Products Company by popularity Ranked #4 in Shanghai Gan An Acids Company by popularity Ranked #4 in Shanghai Dan Bai Yao Products Company by popularity Ranked #4 in Shanghai Yao Wu Shai Xuan Company by popularity
  • Honors: 国药准字 高新技术企业 According to algorithm
  • Salary: 79% of positions earn 8-30K, In 2026 vs last yeardecreased by 2%.。Master's salary: ¥27.0K, Doctorate salary: ¥50.0K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 38.8%, "Computer/Network/Technology": 26.9%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 17.9%。
  • Recruiting: In 2026 vs 2025grew by 10%. Demand for highly educated talent: Master's: 4, Doctorate: 1.
  • Requirement: Education: 大专 leads with 40.3%. Experience: 1-3年 leads with 43.3%.
  • Region: Distributed across 3 regions, 上海: 44.8%, 北京: 22.4%, 成都: 7.5%, 南京: 4.5%.

About the Company

[Summary] Technology creates a healthy life

Shanghai Benemae Pharmaceutical Corporation Limited was founded in 1999, with its headquarters located in Shanghai. It is a high-tech enterprise dedicated to the independent research and development and industrialization of innovative biopharmaceuticals in the fields of endocrinology, cardiovascular diseases, and oncology. Its main products and products under research are all original new drugs independently discovered and developed. Over more than two decades, Benemae Bio has grown into a pioneer in innovative drug R&D for diabetes and has laid out a rich R&D pipeline in metabolism, cardiovascular, and oncology fields.
Yishengtai® Benaglutide injection is an innovative biological drug that took seventeen years of R&D to develop. Since its project initiation, it has successively been signed into major national research projects, including the National Major New Drug Creation Special Project by the Ministry of Science and Technology, Shanghai Strategic Emerging Industry Major Projects, and Shanghai Major Science and Technology Research Projects. Benaglutide injection is currently a GLP-1 class drug whose amino acid sequence is completely identical to that of human origin, primarily used for the treatment of type 2 diabetes. Its creation achieved a breakthrough in zero innovative drugs for diabetes in China. On December 28, 2020, the National Healthcare Security Administration and the Ministry of Human Resources and Social Security issued the National Drug Catalogue for Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2020), and Yishengtai® Benaglutide injection was incorporated into the new medical insurance catalogue.
Since its establishment, the company has always adhered to the core values of "Patient first, Science based," insisted on continuous independent innovation, and actively served unmet clinical needs with solid technical platforms. Over more than twenty years of R&D journey, Benemae Bio has formed a series of core technical platforms covering innovative biopharmaceutical R&D including drug discovery, CMC, clinical research, and others, including target research and drug optimization, protein drug screening and evaluation, genetic engineering tandem expression, construction and screening of high-expression CHO cells, quality research of protein drugs, liquid formulation of biopharmaceuticals, and translational medicine. Benemae Bio has accumulated rich experience in new drug development and a large amount of research data in the field of innovative biopharmaceuticals, providing strong support for the enrichment of its future R&D pipeline. In the field of weight loss treatment, Benemae Bio's product under research, BEM-014, has obtained approval from China's NMPA and entered Phase III clinical trials, and also received clinical trial approval from the U.S. FDA, with clinical studies already initiated in the United States. In the conducted studies, BEM014 has shown clear weight reduction effects, and is expected to become a distinctive innovative drug (the first) for overweight/obesity indications in China in the future. In the field of non-alcoholic fatty liver disease/sthepatitis (NAFLD/NASH) treatment, Benemae Bio's product under research, BEM-050, is currently undergoing preclinical studies, and is about to apply for IND. In addition to laying out advantageous endocrine fields, Benemae Bio has also achieved promising R&D results in cardiovascular and oncology fields.
In the future, Benemae Bio will continue to increase investment in the R&D of original new drugs, build an internationally competitive technology platform, and thereby develop drugs with better efficacy and safety, so that the company's scientific research achievements can better serve more patients, and strive to help patients achieve the beautiful vision of reducing suffering, improving quality of life, and even prolonging life.
In 2014, Benemae Bio was listed on the National SME Share Transfer System, with stock code 830931. Currently, Benemae Bio is actively striving for listing on the Science and Technology Innovation Board.
We sincerely welcome outstanding talents who are willing to grow and develop together with Benemae Bio. Let us join hands and build a better tomorrow for Benemae Bio!
Company address: 916 Ziping Road, Pudong New Area, Shanghai (Shanghai International Medical Park)
Website:

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Benemae Bio How Fast Is Hiring Growing? (21 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 22%
  • 2024: Down 54%
  • 2023: Up 21%
  • 2022: Down 66%
Benemae Bio Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Benemae Bio Campus Recruitment & Advanced Degree Talent Demand
Interns 1 Master's 4 Doctorate 1
Note: How fast is hiring at Shanghai Benemae Pharmaceutical Corporation Limited growing? Benemae Bio2026: 43 openings (up 10%), 2025: 39 openings (up 22%), 2024: 32 openings (down 54%), 2023: 69 openings (up 21%), 2022: 57 openings (down 66%), 2021: 168 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Benemae Bio Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 13%
  • 2024: Down 53%
  • 2023: Down 15%
  • 2022: Up 82%
Benemae Bio Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shanghai Benemae Pharmaceutical Corporation Limited growing? Benemae BioMaster's recruitment over the years: 2025: 7 openings (down 13%), 2024: 8 openings (down 53%), 2023: 17 openings (down 15%), 2022: 20 openings (up 82%), 2021: 11 openings. Benemae Bio master talent ranking in Shanghai: #992, Benemae Bio master salary mostly around 20-50K.

Benemae Bio Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Benemae Bio Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
No.412
Doctoral Demand Ranking in Shanghai 򀀩
¥50K and above-50K and above
Doctoral Salary 򀀩
How fast is doctoral hiring at Shanghai Benemae Pharmaceutical Corporation Limited growing? Benemae BioDoctorate recruitment over the years: 2026: 1 openings (flat), 2024: 6 openings (down 53%), 2023: 11 openings (down 15%), 2022: 10 openings (up 82%), 2021: 6 openings. Benemae Bio doctorate talent ranking in Shanghai: #412, Benemae Bio doctorate salary mostly around 50K and above-50K and above.

Benemae Bio R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shanghai Benemae Pharmaceutical Corporation Limited? Based on an analysis of Benemae Bio's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 38.8%, "Computer/Network/Technology": 26.9%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 17.9%, "Other (R&D and Technical)": 6%, "Mechanical/Instrumentation": 3%, "Scientific Research": 3%. For reference only.

Benemae Bio — What Are the Salaries Like? (67 records)

Manage
Benemae Bio Salary Overview
salary range: 4.5K - 50K, 79% of roles pay ¥8-30K
Note: salary statistics are based on 67 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shanghai Benemae Pharmaceutical Corporation Limited?Benemae Bio79% of positions earn 8-30K, Undergraduate salary: ¥。Shanghai salary ranking: #3718,销售类 average salary ¥17.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Benemae Bio

(More)
Are salaries high at Shanghai Benemae Pharmaceutical Corporation Limited? We provide: Information, Marketing, Pharmaceutical Sales Representative, Operations, New Media Specialist, QA, Analyst, Brand, 医学事务经理, 医学经理, 发酵技术员, 机械维修, 环保, Researcher, Maintenance Technician, 设备管理, Sales, Senior Management, Organization Culture Specialist, ra. Click to view detailed salary analysis by job.

Benemae Bio honors, qualifications & industry associations

Job Category

  • 销售类
    44.8% of total 44.8%
  • 医疗卫生/美容保健类
    38.8% of total 38.8%
  • 计算机/网络/技术类
    26.9% of total 26.9%
  • 生物/制药/化工/环保类
    17.9% of total 17.9%

Education

  • 大专
    40.3% of total 40.3%
  • 本科
    38.8% of total 38.8%
  • 硕士
    16.4% of total 16.4%
  • 高中
    1.5% of total 1.5%

Experience

  • 1-3年
    43.3% of total 43.3%
  • 3-5年
    26.9% of total 26.9%
  • 5-10年
    17.9% of total 17.9%
  • 不限
    11.9% of total 11.9%
View Detailed Analysis

What does Shanghai Benemae Pharmaceutical Corporation Limited require? Who is Benemae Bio hiring? Benemae Bio recruitment: 销售类占比最多占44.8%,其次是医疗卫生/美容保健类占38.8%. What education can get in at Benemae Bio? 大专占比最多占40.3%,其次是本科占38.8%. High education required at Benemae Bio? 硕士占16.4%,博士占1.5%. Work experience required at Benemae Bio? 1-3年占比最多占43.3%,其次是3-5年占26.9%. Where are the job locations at Benemae Bio? 上海占比最多占44.8%,其次是北京占22.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 21,348.1793万(元)
Legal Representative: 桑会庆
Date Established:
Credit Code: 91310000631345793H
Registered Address: 上海市浦东新区周浦镇紫萍路916号

Partners & Suppliers

仁会生物向其采购冻干机等制药设备,用于生产贝那鲁肽注射液。 Source
供应商 制药设备
仁会生物向其采购药用玻璃瓶,用于贝那鲁肽注射液的内包装。 Source
供应商 药用包材(玻璃)
仁会生物向南京医药销售药品,用于华东地区医院终端覆盖。 Source
合作客户 医药商业渠道
仁会生物通过上海医药的分销网络在上海地区销售药品。 Source
合作客户 医药商业渠道
仁会生物将药品销售给九州通,由九州通进行区域分销。 Source
合作客户 医药商业渠道

People who follow Benemae Bio also follow

Benemae Bio Competitors (Similar Companies)

“Plus Ruis is a clinical research service provider.”
临床研究 药物研发 新药研发 转化医学
“Research, development, and production of anti-tumor and surgical medic”
“Professional services for the entire clinical trial process of drug pr”
传真机 一体机 扫描仪 经销商
电子商务 生产 毛衫 套头毛衣
“Primarily engaged in the R&D, production, and sales of low-voltage ele”
研发 自动化技术 智能照明控制 照明控制
零售 销售 连锁 直营
“A professional integrated industry and trade company engaged in the de”
软件 CRM 经销商 汽车产业链
鸡蛋 鸡苗 蛋鸡苗 有机肥料
“Dedicated to providing high-purity process system solutions for high-e”
“Let everyone have trust and expectation in Baili because of health!”
光刻胶 聚合物 材料科技 半导体光刻

Discover Great Companies, Discover Great Clients

上海公司名录 上海“Pudong New Area”公司名录 上海“生物医药”公司名录 上海“基因工程”公司名录 上海“药物研发”公司名录 上海“多肽”公司名录 上海“制药/药业”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates